Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Short term Debt: 2009-2025

Historic Short term Debt for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $2.0 million.

  • China Pharma Holdings' Short term Debt rose 87.75% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 87.75%. This contributed to the annual value of $1.1 million for FY2024, which is 0.99% up from last year.
  • Latest data reveals that China Pharma Holdings reported Short term Debt of $2.0 million as of Q3 2025, which was up 38.95% from $1.4 million recorded in Q2 2025.
  • China Pharma Holdings' Short term Debt's 5-year high stood at $4.3 million during Q3 2021, with a 5-year trough of $1.0 million in Q3 2023.
  • In the last 3 years, China Pharma Holdings' Short term Debt had a median value of $1.1 million in 2024 and averaged $1.5 million.
  • As far as peak fluctuations go, China Pharma Holdings' Short term Debt spiked by 112.48% in 2022, and later plummeted by 66.73% in 2023.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Short term Debt stood at $4.3 million in 2021, then slumped by 43.61% to $2.4 million in 2022, then plummeted by 53.55% to $1.1 million in 2023, then climbed by 0.99% to $1.1 million in 2024, then soared by 87.75% to $2.0 million in 2025.
  • Its Short term Debt stands at $2.0 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.2 million for Q1 2025.